Skip to main content

Lisinopril

NDC 0615-8253 · NCS HealthCare of KY, LLC dba Vangard Labs

Generic nameLisinopril
Dosage formTABLET
RouteORAL
Active ingredient(s)LISINOPRIL
Strength5 mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
Marketing categoryANDA

Packages

0615-8253-05 — 15 TABLET in 1 BLISTER PACK (0615-8253-05)

0615-8253-39 — 30 TABLET in 1 BLISTER PACK (0615-8253-39)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0591-0405 — Lisinopril, 0591-0406 — Lisinopril, 0591-0407 — Lisinopril, 0591-0408 — Lisinopril, 0591-0409 — Lisinopril, 0591-0860 — Lisinopril and Hydrochlorothiazide, 0591-0861 — Lisinopril and Hydrochlorothiazide, 0591-0862 — Lisinopril and Hydrochlorothiazide, 0591-0885 — Lisinopril, 0615-8252 — Lisinopril, 0615-8254 — Lisinopril, 0615-8255 — Lisinopril, 0615-8405 — Lisinopril, 0615-8548 — Lisinopril, 0904-6797 — Lisinopril, 0904-6798 — Lisinopril, 0904-6799 — Lisinopril, 0904-7200 — Lisinopril, 23155-876 — lisinopril, 23155-877 — lisinopril, +342 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels